Fig. 5From: Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life studyMean ± SEM change in BCVA from baseline measured in ETDRS letters for patients treated with Ranibizumab, Aflibercept and BevacizumabBack to article page